Michał Piwoński

Michał Piwoński

Auto-generated profile, based on publicly available information

Michał Piwoński

Medical University of Lublin

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Cells
Verified
Journal Article
Open access
PDF file
KSKatarzyna Szklener
Katarzyna Szklener
AMAdam Grzegorz Michalski
Adam Grzegorz Michalski
KŻKlaudia Żak
Klaudia Żak
MPMichał Piwoński
Michał Piwoński
SMSławomir Mandziuk
Sławomir Mandziuk
Bruton’s Tyrosine Kinase (BTK) is considered crucial in the activation and survival of both physiological and malignant B-cells. In recent years, ibrutinib, an oral BTK inhibitor, became a breakthrough therapy for hematological malignancies, such as chronic lymphocytic. However, ibrutinib’s feasibility might not end there. Several other kinases with established involvement with solid malignancies (i.e., EGFR, HER2) have been found to be inhibited by this agent. Recent discoveries indicate that BTK is a potential anti-solid tumor therapy target. Consequently, ibrutinib, a BTK-inhibitor, has been studied as a therapeutic option in solid malignancies. While most preclinical studies indicate ibrutinib to be an effective therapeutic option in some specific indications, such as NSCLC and breast cancer, clinical trials contradict these observations. Nevertheless, while ibrutinib failed as a monotherapy, it might become an interesting part of a multidrug regime: not only has a synergism between ibrutinib and other compounds, such as trametinib or dactolisib, been observed in vitro, but this BTK inhibitor has also been established as a radio- and chemosensitizer. This review aims to describe the milestones in translating BTK inhibitors to solid tumors in order to understand the future potential of this agent better.

1 September 2020 in Journal of Education, Health and Sport
Verified
Journal Article
Closed access
PDF file
KŻKlaudia Żak
Klaudia Żak
MLMilena Leziak
Milena Leziak
SNSylwiusz Niedobylski
Sylwiusz Niedobylski
MPMichał Piwoński
Michał Piwoński
KLKatarzyna Laszczak
Katarzyna Laszczak
Introduction and purpose: The problem with infertility affects between 8 and 12% of reproductive-aged couples. Among the reasons, smoking, adulterated food, hormonal disorder are featured. Our purpose is to check how micronutrients impact fertility.Brief description of the state of knowledge: Micronutrients deficiency, specifically zinc and selenium deficiencies have also unpropitious impact on fertility. In this review, the potential role of these microelements in male and female reproductive health is considered. Zinc had been proved to regulate sperm motility, spermatogenesis and reduce oxidative stress. Lower delivery of selenium decrease testosterone level by causing changes in receptor of the luteinising hormone. It is also compared with lower spermatozoa concentration. In this review the role of iron, manganese, lead, nickel, copper, magnesium and cobalt is described as well. Summary: Deficiencies of some micronutrients may make worse the fertility. That’s the reason why additional supplementation may be important in the treatment of infertility.

1 July 2020 in Journal of Education, Health and Sport
Verified
Journal Article
Closed access
PDF file
MLMilena Leziak
Milena Leziak
SNSylwiusz Niedobylski
Sylwiusz Niedobylski
KŻKlaudia Żak
Klaudia Żak
MPMichał Piwoński
Michał Piwoński
DKDanuta Krasowska
Danuta Krasowska
Katarzyna Skórzyńska-DziduszkoKatarzyna Skórzyńska-Dziduszko
Katarzyna Skórzyńska-Dziduszko
Introduction and purpose: Postpartum depression (PPD) is one of the most common conditions in childbearing. It is estimated that 10-15% of mothers develop PPD. Oxytocin has recently been implicated in the pathophysiology of several neuropsychiatric disorders including PPD. The aim of this study is to, on the base of recent studies, investigate whether oxytocin has an impact on PPD and if it can be used as a way of diagnostic indicator or treatment. Brief description of the state of knowledgement: Studies indicate that there is a relationship between oxytocin and PPD. Depression and anxiety after delivery were observed more frequently among women with lower oxytocin plasma levels. Basing on the oxytocin plasma levels in the third semester of pregnancy, the risk of PPD can be predicted. This relationship was observed in women who were breastfeeding as well as in those who cessed. Some studies indicate that depression development may be inhibited thanks to oxytocin. Exogenous oxytocin has been proven to improve prosocial behaviour and reduce negative emotional responses in mother-children relations. It may also increase mother’s attention to baby. Some studies have stated that intrapartum oxytocin administration decreases the rate of PPD symptoms but studies on treatment with oxytocin are not unanimous. Conclusions: Oxytocin plays an undeniable role in pathophysiology of postpartum depression and it may be regarded as a diagnostic indicator and therapeutic target. However, more studies are needed to clarify this intricate relationship.

7 September 2021 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
PSPaweł Stanicki
Paweł Stanicki
KNKatarzyna Nowakowska
Katarzyna Nowakowska
MPMichał Piwoński
Michał Piwoński
KŻKlaudia Żak
Klaudia Żak
SNSylwiusz Niedobylski
Sylwiusz Niedobylski
POPaweł Oszczędłowski
Paweł Oszczędłowski
Introduction and purposeArtificial intelligence (AI) is more advanced than ever and finds more and more new applications. Attempts are being made to use computer data analysis in medicine. The aim of this study is to summarize the knowledge on the use of AI in the diagnosis of breast, prostate, skin and colorectal cancer with particular emphasis on the applications and effectiveness of AI in making diagnoses. A brief description of the state of knowledgeThe most frequently used form of artificial intelligence in diagnostics are algorithms that analyze databases and recognize patterns. They can capture the features of samples characteristic of tumors, such as abnormal cells in the biopsy material or the alarming size and color of the skin lesion. Additionally, AI is capable of analyzing magnetic resonance images, radiographs, and other standardized test results. In most cases, AI is more effective than clinicians, sometimes as effective as they are, and almost never less effective. As a rule, the most accurate and adequate diagnosis can be obtained by joining the forces of AI and medical specialists. Working with learning algorithms requires the use of very extensive data sets. Every effort should be made to protect sensitive information from patients' medical history. ConclusionsThe results of research on the effectiveness of AI in cancer diagnostics are very promising. Further research and development of information technology systems may positively affect the quality and effectiveness of tumor diagnostics.

16 September 2021 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MPMichał Piwoński
Michał Piwoński
KŻKlaudia Żak
Klaudia Żak
SNSylwiusz Niedobylski
Sylwiusz Niedobylski
PSPaweł Stanicki
Paweł Stanicki
Tumor lysis syndrome (TLS) is an acute, life-threatening condition that occurs either spontaneously or as a complication of cytoreductive antitumor therapy, and occurs in both children and adults. As a result of TLS, intracellular components are released into the extracellular space, leading to dysregulation of the body's homeostasis due to the accumulation of uric acid, phosphate and potassium ions, and hypocalcemia, which may lead to cardiac arrhythmias, convulsions, or kidney failure.

28 July 2020 in Journal of Education, Health and Sport
Verified
Journal Article
Closed access
PDF file
MPMichał Piwoński
Michał Piwoński
KŻKlaudia Żak
Klaudia Żak
MKMarta Kozłowska
Marta Kozłowska
BZBartłomiej Zaremba
Bartłomiej Zaremba
JMJoanna Milanowska
Joanna Milanowska
Introduction and objective: Prader-Willi syndrome (PWS) is a severe genetic disorder being manifested by several symptoms such as infantile hypotonia and poor thriving outcomes, low height, hyperphagia, endocrine, reproductive and internal malfunctions and malformations. In the disease treatment, growth hormone (GH)-replacement therapy is commonly carried on. In this article, we sum up the latest clinical trials’ results concerning the effectiveness and safety of GH-replacement therapy.Abbreviated description of the state of knowledge: Taking into consideration six clinical trials performed in the years 2019-2020, most of them showed positive results of GH-replacement therapy in PWS patients, not only in case of better motor skills or body composition, but also concerning their social and adaptive functioning. Moreover, as for the cessation of GH treatment, some authors seem to highlight no deterioration in cognitive functioning in patients who attained adult height after GH-treatment.Summary: GH-replacement therapy seems to be a good therapeutic option for PWS-affected individuals. Nonetheless, in our research we did not come across on any clinical trials with more than one-year-long observations. Thus, on the long term, these results can not exclude a gradual deterioration of cognitive functioning.